Mannheim, Germany

Bernd Leipold


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Leipold - Innovating Pain Management in Mannheim

Introduction

Bernd Leipold, an accomplished inventor based in Mannheim, Germany, has made significant strides in the field of analgesics. With his innovative approach, he has developed a unique fast-acting analgesic formula that utilizes ibuprofen as its core active ingredient. His work is pivotal in providing rapid relief from pain, showcasing his dedication to enhancing patient care through effective medication.

Latest Patents

Leipold holds a notable patent for his invention titled "Fast-acting analgesic." This patent describes a formulation comprising ibuprofen integrated within an adjuvant matrix characterized by a porous structure. The matrix has a unique density ranging from greater than 1 g/cm³ up to 2.5 g/cm³, which aids in the quick release of the analgesic substance, thus ensuring rapid pain relief for users.

Career Highlights

As an inventor at BASF Aktiengesellschaft, one of the world’s premier chemical companies, Leipold has been able to leverage the resources and expertise available to him. His invention reflects a commitment to research and development, resulting in improved therapeutic outcomes. His time at BASF has allowed him to work at the forefront of pharmaceutical innovations.

Collaborations

Leipold's collaborative spirit is evident through his partnerships with colleagues such as Jürgen Zeidler and Jörg Neumann. Together, they contribute to a dynamic team environment that fosters creativity and innovation. Their joint efforts speak to the collaborative nature of research and the importance of teamwork in driving successful outcomes in the pharmaceutical industry.

Conclusion

Bernd Leipold stands out as a pioneering inventor in the realm of analgesics, with his fast-acting formulation representing a significant advancement in pain management. His affiliation with BASF Aktiengesellschaft, combined with his collaborative work with esteemed colleagues, positions him as a key contributor to the development of effective pain relief solutions. Through his innovations, Leipold continues to impact the healthcare landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…